PortalPublikationenAssessment of the enhancement in predictive accuracy provide...

Assessment of the enhancement in predictive accuracy provided by systematic biopsy in predicting outcome for clinically localized prostate cancer.

Standard

Assessment of the enhancement in predictive accuracy provided by systematic biopsy in predicting outcome for clinically localized prostate cancer. / Graefen, Markus; Ohori, Makoto; Karakiewicz, Pierre I; Cagiannos, Ilias; Hammerer, Peter G; Haese, Alexander; Erbersdobler, Andreas; Henke, Rolf-Peter; Huland, Hartwig; Wheeler, Thomas M; Slawin, Kevin; Scardino, Peter T; Kattan, Michael W.

in: J UROLOGY, Jahrgang 171, Nr. 1, 1, 2004, S. 200-203.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Graefen, M, Ohori, M, Karakiewicz, PI, Cagiannos, I, Hammerer, PG, Haese, A, Erbersdobler, A, Henke, R-P, Huland, H, Wheeler, TM, Slawin, K, Scardino, PT & Kattan, MW 2004, 'Assessment of the enhancement in predictive accuracy provided by systematic biopsy in predicting outcome for clinically localized prostate cancer.', J UROLOGY, Jg. 171, Nr. 1, 1, S. 200-203. <http://www.ncbi.nlm.nih.gov/pubmed/14665876?dopt=Citation>

APA

Graefen, M., Ohori, M., Karakiewicz, P. I., Cagiannos, I., Hammerer, P. G., Haese, A., Erbersdobler, A., Henke, R-P., Huland, H., Wheeler, T. M., Slawin, K., Scardino, P. T., & Kattan, M. W. (2004). Assessment of the enhancement in predictive accuracy provided by systematic biopsy in predicting outcome for clinically localized prostate cancer. J UROLOGY, 171(1), 200-203. [1]. http://www.ncbi.nlm.nih.gov/pubmed/14665876?dopt=Citation

Vancouver

Graefen M, Ohori M, Karakiewicz PI, Cagiannos I, Hammerer PG, Haese A et al. Assessment of the enhancement in predictive accuracy provided by systematic biopsy in predicting outcome for clinically localized prostate cancer. J UROLOGY. 2004;171(1):200-203. 1.

Bibtex

@article{43b6a583c354442ab2a2ba945bf6ef0a,
title = "Assessment of the enhancement in predictive accuracy provided by systematic biopsy in predicting outcome for clinically localized prostate cancer.",
abstract = "PURPOSE: Current localized prostate cancer treatment outcome nomograms rely on prostate specific antigen (PSA), tumor stage and grade. We investigated whether the addition of prostate biopsy features may enhance the accuracy of a nomogram predicting recurrence after radical prostatectomy (RP). MATERIALS AND METHODS: Clinical data from 1,152 patients who underwent RP were used and included PSA, clinical stage, biopsy Gleason grade and systematic biopsy information that quantified the amount of cancer and high grade cancer. Predictive accuracy for freedom from recurrence after RP was assessed with and without tumor quantification in the biopsy by the area under the receiver operating characteristics curve (AUC). RESULTS: Percentage and number of cores with cancer, and percentage and number of cores with high grade cancer were predictors of outcome when added to models that included PSA, Gleason grade and clinical stage (all p",
author = "Markus Graefen and Makoto Ohori and Karakiewicz, {Pierre I} and Ilias Cagiannos and Hammerer, {Peter G} and Alexander Haese and Andreas Erbersdobler and Rolf-Peter Henke and Hartwig Huland and Wheeler, {Thomas M} and Kevin Slawin and Scardino, {Peter T} and Kattan, {Michael W}",
year = "2004",
language = "Deutsch",
volume = "171",
pages = "200--203",
journal = "J UROLOGY",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "1",

}

RIS

TY - JOUR

T1 - Assessment of the enhancement in predictive accuracy provided by systematic biopsy in predicting outcome for clinically localized prostate cancer.

AU - Graefen, Markus

AU - Ohori, Makoto

AU - Karakiewicz, Pierre I

AU - Cagiannos, Ilias

AU - Hammerer, Peter G

AU - Haese, Alexander

AU - Erbersdobler, Andreas

AU - Henke, Rolf-Peter

AU - Huland, Hartwig

AU - Wheeler, Thomas M

AU - Slawin, Kevin

AU - Scardino, Peter T

AU - Kattan, Michael W

PY - 2004

Y1 - 2004

N2 - PURPOSE: Current localized prostate cancer treatment outcome nomograms rely on prostate specific antigen (PSA), tumor stage and grade. We investigated whether the addition of prostate biopsy features may enhance the accuracy of a nomogram predicting recurrence after radical prostatectomy (RP). MATERIALS AND METHODS: Clinical data from 1,152 patients who underwent RP were used and included PSA, clinical stage, biopsy Gleason grade and systematic biopsy information that quantified the amount of cancer and high grade cancer. Predictive accuracy for freedom from recurrence after RP was assessed with and without tumor quantification in the biopsy by the area under the receiver operating characteristics curve (AUC). RESULTS: Percentage and number of cores with cancer, and percentage and number of cores with high grade cancer were predictors of outcome when added to models that included PSA, Gleason grade and clinical stage (all p

AB - PURPOSE: Current localized prostate cancer treatment outcome nomograms rely on prostate specific antigen (PSA), tumor stage and grade. We investigated whether the addition of prostate biopsy features may enhance the accuracy of a nomogram predicting recurrence after radical prostatectomy (RP). MATERIALS AND METHODS: Clinical data from 1,152 patients who underwent RP were used and included PSA, clinical stage, biopsy Gleason grade and systematic biopsy information that quantified the amount of cancer and high grade cancer. Predictive accuracy for freedom from recurrence after RP was assessed with and without tumor quantification in the biopsy by the area under the receiver operating characteristics curve (AUC). RESULTS: Percentage and number of cores with cancer, and percentage and number of cores with high grade cancer were predictors of outcome when added to models that included PSA, Gleason grade and clinical stage (all p

M3 - SCORING: Zeitschriftenaufsatz

VL - 171

SP - 200

EP - 203

JO - J UROLOGY

JF - J UROLOGY

SN - 0022-5347

IS - 1

M1 - 1

ER -